|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 37.62 USD | +0.44% |
|
+4.43% | +4.84% |
| Capitalization | 4.59B 3.98B 3.65B 3.44B 6.39B 435B 6.51B 43.38B 16.87B 211B 17.22B 16.84B 735B | P/E ratio 2026 * |
11.8x | P/E ratio 2027 * | 10.9x |
|---|---|---|---|---|---|
| Enterprise value | 4.64B 4.03B 3.69B 3.48B 6.47B 441B 6.59B 43.9B 17.07B 214B 17.42B 17.04B 744B | EV / Sales 2026 * |
3.69x | EV / Sales 2027 * | 3.25x |
| Free-Float |
97.76% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Indivior Pharmaceuticals, Inc.
| 1 day | +0.44% | ||
| 1 week | +4.43% | ||
| Current month | +4.43% | ||
| 1 month | -7.38% | ||
| 3 months | +16.56% | ||
| 6 months | +7.10% | ||
| Current year | +4.84% |
| 1 week | 32.41 | 38.52 | |
| 1 month | 32.41 | 40.05 | |
| Current year | 27.68 | 41 | |
| 1 year | 13.42 | 41 | |
| 3 years | 7.33 | 41 | |
| 5 years | 7.33 | 41 | |
| 10 years | 1.75 | 41 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05-13 | Free | Director | 6,518 | 0.0053% | ||
| 05-13 | Free | Director | 6,518 | 0.0053% | ||
| 05-13 | Free | Director | 6,518 | 0.0053% |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.44% | +4.43% | +167.34% | +83.49% | 4.59B | ||
| +0.55% | +2.39% | +46.96% | +155.36% | 1,009B | ||
| +2.02% | +3.30% | +50.15% | +47.16% | 560B | ||
| +1.02% | +4.37% | +19.70% | +67.78% | 401B | ||
| +0.77% | -0.67% | +22.19% | +12.23% | 328B | ||
| +2.24% | +0.41% | +29.51% | +17.50% | 288B | ||
| +1.85% | +0.14% | +22.04% | +30.54% | 272B | ||
| +4.43% | -3.11% | -40.46% | -47.48% | 194B | ||
| +1.15% | +3.80% | +20.41% | +58.02% | 189B | ||
| -0.02% | -3.92% | +14.85% | +69.50% | 160B | ||
| Average | +1.44% | +1.47% | +35.27% | +49.41% | 340.6B | |
| Weighted average by Cap. | +1.34% | +1.95% | +30.62% | +70.75% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.26B 1.09B 1B 943M 1.75B 119B 1.79B 11.9B 4.63B 57.92B 4.72B 4.62B 202B | 1.29B 1.12B 1.03B 965M 1.79B 122B 1.83B 12.18B 4.74B 59.27B 4.83B 4.73B 206B |
| Net income | 414M 360M 330M 311M 577M 39.35B 588M 3.92B 1.52B 19.08B 1.56B 1.52B 66.44B | 455M 395M 362M 341M 634M 43.19B 646M 4.3B 1.67B 20.94B 1.71B 1.67B 72.92B |
| Net Debt | 54.5M 47.32M 43.39M 40.86M 75.93M 5.17B 77.36M 516M 201M 2.51B 205M 200M 8.74B | -403M -350M -321M -302M -562M -38.3B -573M -3.82B -1.48B -18.57B -1.51B -1.48B -64.66B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/06/26 | 37.62 $ | +0.44% | 1,586,982 |
| 04/06/26 | 37.45 $ | +5.70% | 1,911,176 |
| 03/06/26 | 35.43 $ | +5.10% | 1,535,384 |
| 02/06/26 | 33.71 $ | -3.35% | 2,917,607 |
| 01/06/26 | 34.88 $ | -3.16% | 2,069,191 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- INDV Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
















